← Open Payments lookup

KIMBERLY HARDIN: Open Payments

NPI 1841392784 · NEW ALBANY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,822 in 128 payments from 31 companies in 2025. Trend: 2023 $2,938 · 2024 $2,408 · 2025 $2,822

Food & beverage: $2,484Education: $338
CompanyPaymentsAmount
Astellas Pharma US Inc8$388
Novartis Pharmaceuticals Corporation15$264
E.R. Squibb & Sons, L.L.C.16$256
Gilead Sciences, Inc.8$187
PFIZER INC.9$183
Merck Sharp & Dohme LLC9$180
Celgene Corporation5$136
Eisai Inc.7$126
Lilly USA, LLC5$107
Janssen Biotech, Inc.4$95

Products named: Trodelvy, KEYTRUDA, OPDIVO, PADCEV, KISQALI, REBLOZYL, Lenvima, ENHERTU.

Industry payments across MS — which companies pay providers there.